CD4 and myeloid sarcoma: Indeed, it has been shown in a mouse model of MS, MOG-induced EAE, that administration of an anti-NKG2A F(ab)'2 fragment results in potent NK cell-mediated elimination of infiltrating pathogenic CD4+ T cells and microglia, and amelioration of EAE [9], [10].